Physician profile
Robert K Bruner
NPI 1972599959
$1,786.35
in general payments reported to CMS, 2019-2025
16 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $114 · 2021: $220 · 2023: $17.27 · 2024: $25.25 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $590.24 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $212.21 | 2019-2025 | |
| Amgen INC. | $179.50 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.07 | 2019-2025 | Jardiance |
| Abbott Laboratories | $163.24 | 2019-2021 | |
| Atricure, INC. | $151.65 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals Lp | $52.78 | 2019 | |
| Sanofi-Aventis U.S. LLC | $51.56 | 2019 | |
| Edwards Lifesciences Corporation | $49.27 | 2019 | |
| Pfizer INC. | $34.06 | 2019-2025 | |
| Novo Nordisk INC | $28.65 | 2025 | Wegovy |
| Celgene Corporation | $25.25 | 2024 | Camzyos |
| Medtronic, INC. | $22.26 | 2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $21.69 | 2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.71 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.